A technology of an antilipolytic dietary supplement based on phenolic compounds and biopolymers of pleurotus ostreatus

Authors

  • Natalya Cherno Odessa National Academy of Food Technologies Str. Kanatnya 112, Odessa, Ukraine, 65039, Ukraine
  • Sophya Osolina Odessa National Academy of Food Technologies Kanatnya 112 str., Odessa, Ukraine, 65039, Ukraine https://orcid.org/0000-0001-8116-8160
  • Olexandra Nikitina Problem research laboratory Kanatnya 112 str., Odessa, Ukraine, 65039, Ukraine https://orcid.org/0000-0002-2136-5610

DOI:

https://doi.org/10.15587/1729-4061.2016.64824

Keywords:

technology, dietary supplement, lipase inhibitor, biopolymer complex, mushrooms, rapeseed

Abstract

A rapid increase in the number of people suffering from abnormal weight gain is observed worldwide. Scientists have discovered a causal relationship between obesity and a number of serious diseases. At present, the only means used for correcting body weight is orlistat, which is a semi-synthetic medicine of non-Ukrainian production and a remedy that is not devoid of side effects.

Our aim was to develop a technology of obtaining a dietary supplement that would produce antylipolitic effect and be based on substances of vegetable origin: phenolic compounds of rapeseed and a biopolymer complex of oyster mushrooms.

It has been determined that the inhibitory activity of phenolic compounds of rapeseed that are immobilized on the biopolymer matrix of oyster mushrooms depends on the conditions of obtaining the latter. The highest levels of antylipolitic activity were found in antylipolitic preparations derived from the biopolymer complex that had been obtained through treating the raw material with water, acid, and a 7 % solution of sodium hydroxide. The selected duration of contact with the alkaline agent is 90 min.

Rational conditions have been established for immobilization of the inhibitor on the carrier: saturation of the matrix with a 0.17% solution of phenolic compounds of rapeseed (hydrological module 6) at a temperature of +20-25°C for 20 minutes. Samples with an immobilized inhibitor have been found to surpass the intact form according to such properties as pH stability, thermal stability, stability under conditions simulating the gastrointestinal tract, and stability in storage.

We have developed a technology of obtaining a dietary supplement of antylipolitic effect. The dietary supplement contains 1% of phenolic compounds of rapeseed while the rest of the structure consists of a biopolymer complex of oyster mushrooms that includes glucan, chitin, melanins, and protein. It is characterized by high levels of antylipolitic, antioxidant and enterosorption activities; moreover, it is able to stimulate growth of lactobacteria and bifidobacteria as well as to respond to the normalized indicators of microbiological safety.

Author Biographies

Natalya Cherno, Odessa National Academy of Food Technologies Str. Kanatnya 112, Odessa, Ukraine, 65039

Doctor of technical sciences, Professor, head of the department

Department of food chemistry

Sophya Osolina, Odessa National Academy of Food Technologies Kanatnya 112 str., Odessa, Ukraine, 65039

Candidate of chemical science, Associate professor

Department of food chemistry

Olexandra Nikitina, Problem research laboratory Kanatnya 112 str., Odessa, Ukraine, 65039

PhD, Scientific researcher

References

  1. Lavie, C. J., Milani, R. V., Artham, S. M., Patel, D. A., Ventura, H. O. (2009). The Obesity Paradox, Weight Loss, and Coronary Disease. The American Journal of Medicine, 122 (12), 1106–1114. doi: 10.1016/j.amjmed.2009.06.006
  2. Uretsky, S., Messerli, F. H., Bangalore, S., Champion, A., Cooper-DeHoff, R. M., Zhou, Q., Pepine, C. J. (2007). Obesity Paradox in Patients with Hypertension and Coronary Artery Disease. The American Journal of Medicine, 120 (10), 863–870. doi: 10.1016/j.amjmed.2007.05.011
  3. Rahmouni, K., Correia, M. L. G., Haynes, W. G., Mark, A. L. (2004). Obesity-Associated Hypertension: New Insights Into Mechanisms. Hypertension, 45 (1), 9–14. doi: 10.1161/01.hyp.0000151325.83008.b4
  4. Ogden, C. L., Yanovski, S. Z., Carroll, M. D., Flegal, K. M. (2007). The Epidemiology of Obesity. Gastroenterology, 132 (6), 2087–2102. doi: 10.1053/j.gastro.2007.03.052
  5. Avenell, A., Brown, T. J., McGee, M. A., Campbell, M. K., Grant, A. M., Broom, J. et. al. (2004). What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. Journal of Human Nutrition and Dietetics, 17 (4), 317–335. doi: 10.1111/j.1365-277x.2004.00531.x
  6. Ohkawara, K., Tanaka, S., Miyachi, M., Ishikawa-Takata, K., Tabata, I. (2007). A dose–response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials. International Journal of Obesity, 31 (12), 1786–1797. doi: 10.1038/sj.ijo.0803683
  7. Guire, M. M., Beerman, K. A. (2012). Nutritional Sciences: From Fundamentals to Food. 3rd edition. N.J., Wadsworth Cengage Learning, 736.
  8. Mertens, I. L., van Gaal, L. F. (2000). Overweight, Obesity, and Blood Pressure: The Effects of Modest Weight Reduction. Obesity Research, 8 (3), 270–278. doi: 10.1038/oby.2000.32
  9. Glazer, G. (2001). Long-term Pharmacotherapy of Obesity 2000. Archives of Internal Medicine, 161 (15), 1814–1824. doi: 10.1001/archinte.161.15.1814
  10. James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P. et. al. (2010). Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects. New England Journal of Medicine, 363 (10), 905–917. doi: 10.1056/nejmoa1003114
  11. Chanoine, J.-P., Hampl, S., Jensen, C., Boldrin, M., Hauptman, J. (2005). Effect of Orlistat on Weight and Body Composition in Obese Adolescents. JAMA, 293 (23), 2873–2883. doi: 10.1001/jama.293.23.2873
  12. Maahs, D., Serna, D. G. de, Kolotkin, R. L., Ralston, S., Sandate, J., Qualls, C., Schade, D. S. (2006). Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. Endocrine Practice, 12 (1), 18–28. doi: 10.4158/ep.12.1.18
  13. Grinevich, V. B., Sas, E. I., Kravchuk, Yu. A., Efimov, O. I. (2012). Abdominal obesity: clinical and social aspects of the problem. Farmateca, 16, 29–34.
  14. Cherno, N. K., Krusir, G. V., Yashkina, V. V. (2004). Prospects for the use of certain types of vegetable raw materials as lipase inhibitors. Cereals and fodder, 3, 15–17.
  15. Zhbankov, R. G. (1992). IR-spectra and carbohydrate structure. Minsk: Science, 456.
  16. Cherno, N. К., Osolina, S. A., Nikitina, A. V. (2013). Chemical composition of Agaricus bisporus and Pleurotus ostreatus fruting bodies and their morphological parts. Food and Environment Safety, 4, 291–299.
  17. Chung, C., Nickerson, W. (1954). Polysaccharide synthesis in growing yeast. J. Biol. Chem., 208, 395–407.
  18. Laine, R. A., Esselman, W. J., Sweeley, C. C. (1972). [10] Gas-liquid chromatography of carbohydrates. Complex Carbohydrates Part B, 18, 159–167. doi: 10.1016/0076-6879(72)28012-0
  19. Smith, R. L., Gilkerson, E. (1979). Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Analytical Biochemistry, 98 (2), 478–480. doi: 10.1016/0003-2697(79)90170-2
  20. Selvakumar, P., Rajasekar, S., Periasamy, K., Raaman, N. (2008). Isolation and characterization of melanin pigment from Pleurotus cystidiosus (telomorph of Antromycopsis macrocarpa). World Journal of Microbiology and Biotechnology, 24 (10), 2125–2131. doi: 10.1007/s11274-008-9718-2
  21. Ofenbeher-Miletić, I., Stanimirović, D., Stanimirović, S. (1984). On determination of chitin content in mushrooms. Qualitas Plantarum Plant Foods for Human Nutrition, 34 (3), 197–201. doi: 10.1007/bf01091469
  22. Ragazzi, E., Veronese, G. (1973). Quantitative analysis of phenolic compounds after thin-layer chromatographic separation. Journal of Chromatography A, 77 (2), 369–375. doi: 10.1016/s0021-9673(00)92204-0
  23. Jagdish, P., Deepa, V., Rohan, G., Bhagat, R. D. (2013). Production of Microbial Lipases Isolated From Curd Using Waste Oil as a Substrate. Research J. Pharm., Bio. and Chem. Sci., 4 (3), 831–839.
  24. Nikitina, O. V., Cherno, N. К., Osolina, S. A. (2015). Obtaining and characteristic of biopolymer complexes of Pleurotus ostreatus. Food Science and Technology, 9 (3), 19–25. doi: 10.15673/2073-8684.3/2015.50276

Downloads

Published

2016-04-23

How to Cite

Cherno, N., Osolina, S., & Nikitina, O. (2016). A technology of an antilipolytic dietary supplement based on phenolic compounds and biopolymers of pleurotus ostreatus. Eastern-European Journal of Enterprise Technologies, 2(11(80), 56–63. https://doi.org/10.15587/1729-4061.2016.64824

Issue

Vol. 2 No. 11(80) (2016): Technology and Equipment of Food Production

Section

Technology and Equipment of Food Production

License

Copyright (c) 2016 Natalya Cherno, Sophya Osolina, Olexandra Nikitina

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The consolidation and conditions for the transfer of copyright (identification of authorship) is carried out in the License Agreement. In particular, the authors reserve the right to the authorship of their manuscript and transfer the first publication of this work to the journal under the terms of the Creative Commons CC BY license. At the same time, they have the right to conclude on their own additional agreements concerning the non-exclusive distribution of the work in the form in which it was published by this journal, but provided that the link to the first publication of the article in this journal is preserved.

A license agreement is a document in which the author warrants that he/she owns all copyright for the work (manuscript, article, etc.).
The authors, signing the License Agreement with TECHNOLOGY CENTER PC, have all rights to the further use of their work, provided that they link to our edition in which the work was published.
According to the terms of the License Agreement, the Publisher TECHNOLOGY CENTER PC does not take away your copyrights and receives permission from the authors to use and dissemination of the publication through the world's scientific resources (own electronic resources, scientometric databases, repositories, libraries, etc.).
In the absence of a signed License Agreement or in the absence of this agreement of identifiers allowing to identify the identity of the author, the editors have no right to work with the manuscript.
It is important to remember that there is another type of agreement between authors and publishers – when copyright is transferred from the authors to the publisher. In this case, the authors lose ownership of their work and may not use it in any way.